Results 31 to 40 of about 17,743 (275)

Bilateral diffuse pulmonary infiltrates secondary to malignant peritoneal mesothelioma – A rare clinical presentation

open access: yesRespiratory Medicine Case Reports, 2019
Diffuse pulmonary metastasis secondary to primary peritoneal malignant mesothelioma is rarely reported in the literature. In this report we describe a 59-year-old Caucasian women with no known previous asbestos exposure presenting with bilateral diffuse ...
Madeleine Haygarth   +5 more
doaj   +1 more source

In Vitro and in vivo anti-tumoral effects of the flavonoid apigenin in malignant mesothelioma [PDF]

open access: yes, 2017
Malignant mesothelioma (MM) is a tumor arising from mesothelium. MM patients' survival is poor. The polyphenol 4',5,7,-trihydroxyflavone Apigenin (API) is a "multifunctional drug". Several studies have demonstrated API anti-tumoral effects.
Andrea Modesti   +13 more
core   +2 more sources

Single-center retrospective analysis of peritoneal mesothelioma [PDF]

open access: yesJichu yixue yu linchuang
Objective To explore the diagnosis and treatment experience of malignant peritoneal mesothelioma by analyzing the clinical characteristics of patients with single center peritoneal mesothelioma.
LIU Qi, NIE Muwen, ZHANG Jingqi, LI Ningning, ZHAO Lin
doaj   +1 more source

Bacterial Infection Elicits Heat Shock Protein 72 Release from Pleural Mesothelial Cells [PDF]

open access: yes, 2013
Heat shock protein 70 (HSP70) has been implicated in infection-related processes and has been found in body fluids during infection. This study aimed to determine whether pleural mesothelial cells release HSP70 in response to bacterial infection in vitro
Bielsa, S   +8 more
core   +1 more source

CT imaging of malignant peritoneal mesothelioma: A case report

open access: yesRadiology Case Reports, 2022
The peritoneal cavity is the second most common location for mesothelioma with only 10.5% of 10,589 mesothelioma cases reported in the United States between 1973 until 2005 and known with poor prognosis.
Agnes Triana Basja, MD   +1 more
doaj   +1 more source

Curcumin blocks autophagy and activates apoptosis of malignant mesothelioma cell lines and increases the survival of mice intraperitoneally transplanted with a malignant mesothelioma cell line [PDF]

open access: yes, 2017
Malignant mesothelioma (MM) is a primary tumor arising from the serous membranes. The resistance of MM patients to conventional therapies, and the poor patients' survival, encouraged the identification of molecular targets for MM treatment. Curcumin (CUR)
Bei, Roberto   +10 more
core   +1 more source

Diffuse malignant peritoneal mesothelioma

open access: yesKaohsiung Journal of Medical Sciences, 2013
Mesothelioma often originates in the pleura and less frequently in the peritoneum. This article describes a rare case of diffuse malignant peritoneal mesothelioma in a 54-year-old male construction worker who was admitted to our hospital with a 2-month ...
Chih-An Shih   +4 more
doaj   +1 more source

New and emerging therapeutic options for malignant pleural mesothelioma: review of early clinical trials. [PDF]

open access: yes, 2015
Malignant pleural mesothelioma (MPM) is a rare tumor that is challenging to control. Despite some benefit from using the multimodality-approach (surgery, combination chemotherapy and radiation), survival remains poor. However, current research produced a
Cameron, Robert B   +2 more
core   +2 more sources

Diffuse malignant peritoneal mesothelioma mimicking ovarian cancer.

open access: yesRadiology Case Reports, 2022
Diffuse malignant peritoneal mesothelioma (DMPM) and peritoneal carcinomatosis have similar computed tomography imaging features. Peritoneal carcinomatosis is a known metastatic site for many malignancies and particularly gastrointestinal tract and ...
Zaynab Iraqi Houssaini, Intern in radiology   +7 more
doaj   +1 more source

Changing Pattern in Malignant Mesothelioma Survival

open access: yesTranslational Oncology, 2015
Survival for mesothelioma has been shown to be poor, with marginal improvement over time. Recent advances in the understanding of pathophysiology and treatment of mesothelioma may impact therapy to improve survival that may not be evident from available ...
Jennifer Faig   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy